Smart ring maker Oura raises $900M from Fidelity

Finnish health tech company Oura has secured $900 million in new funding led by Fidelity Management & Research Company, valuing the company at approximately $11 billion, more than double its previous valuation. This significant capital injection follows a period of rapid growth, with Oura doubling its revenue to $500 million in 2024 and expecting to exceed $1 billion this year, driven by over 5.5 million smart ring sales and an 80% market share. The funds will be used for AI and production innovation, new health features, and global distribution, as Oura expands into health testing services like blood panels and targets new demographics, intensifying competition with rivals like Whoop and Samsung.

Analysis

Finnish health tech company Oura has successfully secured $900 million in new funding, primarily led by Fidelity Management & Research Company, which values the company at approximately $11 billion. This valuation represents more than double its previous round from last December, indicating robust investor confidence in its growth trajectory and market position.

The company has demonstrated exceptional financial performance, with revenue doubling to $500 million in 2024 and projecting to exceed $1 billion this year. Oura has sold over 5.5 million smart rings, with more than half of these sales occurring in the past year, solidifying its dominant market share of over 80% in the smart ring sector according to IDC.

Strategic deployment of the new capital will focus on AI and production innovation, introducing new health features, and expanding global distribution. Oura is also diversifying its offerings by launching "Health Panels" for blood testing via Quest Diagnostics, intensifying competition with rivals like Whoop and Samsung, while also successfully targeting new demographics such as women in their early twenties.

Key Decisions for Investors

• Investors with exposure to private health tech should note Oura's significant valuation increase and strong revenue growth as indicators of high potential in the wearable health market.
• Monitor Oura's execution on its strategic initiatives, including AI integration, global expansion, and the success of its new health testing services against established and emerging competitors.
• Assess the company's ability to sustain its dominant market share and achieve its ambitious $1 billion revenue target as key performance indicators for long-term viability and potential public market entry.